Skip to content

Analgesic Effect of Trigger Point Injection and EMLA for Shoulder Pain in Laparoscopic Hysterectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01845532
Enrollment
75
Registered
2013-05-03
Start date
2013-04-30
Completion date
2014-01-31
Last updated
2014-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma of Uterus

Brief summary

Laparoscopic operative procedures have revolutionized gynecological surgery. These have several advantages: a smaller and more cosmetic incision, reduced blood loss and shorter postoperative stay, which cuts down on hospital costs. However, postoperative pain continues to be one complication, which results in an unpleasant experience for the patient and at times causes a delayed discharge. Trigger point injection removes the pain developing point and block the pain signal. EMLA cream shows analgesic effect when being spread on the skin. An literature showed that patch of local anesthetics showed the effect of trigger point inject. The purpose of this study is to investigate the alleviation of shoulder pain, headache, abdominal pain, and back pain after trigger point injection or EMLA cream applying on shoulder in patients undergoing total laparoscopic hysterectomy.

Interventions

DRUGTPI

Trigger point injection with 25G needle on the shoulder before surgery(0.5% procaine, 0.25\ 0.5% lidocaine, 0.125% bupivacaine)

EMLA cream with occluding dressing on the shoulder before surgery(5% of eutectic mixture with 2.5% lidocaine and 2.5% prilocaine)

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA class I or II * age 20\ 70 * patients undergoing total laparoscopic hysterectomy

Exclusion criteria

* history of shoulder surgery * coagulopathy * infection or trauma of shoulder * general inflammation * allergy to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
postoperative shoulder pain3 hr after end of surgeryPostoperative shoulder pain is measured using the VAS at 3 hr after end of surgery.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026